Dotbee.ai

Analysis DMCC SPECIALITY CHEMICALS LIMI (DMCC)

6/1/2024

Analysis DMCC SPECIALITY CHEMICALS LIMI (DMCC)

Analysis of DMCC SPECIALITY CHEMICALS LIMI (DMCC)

DMCC Speciality Chemicals Limited (DMCC) has been showing some volatility in its stock price recently. The RSI indicator is hovering around 40-50, indicating a neutral sentiment in the market. The MACD indicator is negative, suggesting a bearish trend in the short term.

The stock price has been fluctuating between $290 and $320 in the past few days, with the latest closing price at $310.20. The moving averages (SMA, EMA, WMA) are all above the current price, indicating a potential resistance level.

Overall, DMCC seems to be in a consolidation phase with no clear trend direction. Traders and investors may want to wait for a clearer signal before making any significant trading decisions.

Earnings

The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.

Main Statystic 🧠

The company's financials show a strong cash flow, with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet indicates a total cash of $67.15 billion and total debt of $104.59 billion, resulting in a current ratio of 1.037. The company has a book value per share of $4.837 and a total cash per share of $4.379, with a total debt to equity ratio of 140.968.

In terms of profitability, the company has a profit margin of 26.31% and an operating margin of 30.74%. The return on assets is 22.07% and the return on equity is 147.25%. The most recent quarter ended on March 31, 2024, with a fiscal year ending on September 30, 2023.

The income statement shows an EBITDA of $131.39 billion, revenue of $381.62 billion, and a net income to common of $100.39 billion. The diluted EPS is $6.43, with a revenue per share of $24.54. The company experienced a negative quarterly revenue growth of -4.3% and a negative quarterly earnings growth year over year of -2.2%.

In terms of stock statistics, the company has a short ratio of 1.53 and a short percent of shares outstanding of 0.65%. The float shares are 15.31 billion, with 99.29 million shares shorted. The shares outstanding are 15.33 billion, with 5.22% held by insiders and 57.59% held by institutions.

The valuation metrics show a PEG ratio of 26.32, a forward PE of 26.32, and a trailing PE of 29.59. The enterprise value is $2.95 trillion, with a price to book ratio of 39.34 and a price to sales ratio of 7.65. The enterprise to EBITDA ratio is 22.76 and the enterprise to revenue ratio is 7.73. The market capitalization is $2.92 trillion.

In terms of stock price summary, the beta is 1.26, with a 50-day moving average of $176.26 and a 200-day moving average of $181.04. The fifty-two week low is $164.08, the high is $199.62, and the change is 6.85%.

Regarding dividends and splits, the company has a payout ratio of 14.93% and a forward annual dividend rate of $1. The 5-year average dividend yield is 0.73%, with a forward annual dividend yield of 0.53% and a trailing annual dividend yield of 0.51%. The dividend date is May 16, 2024, with an ex-dividend date of May 10, 2024. The last split date was on August 31, 2020, with a 4-for-1 split.

Income statement 💸

Here are the revenue figures for the company over the past four fiscal years:

1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000

From these figures, we can observe the following trends:
- The company experienced a decrease in sales from 2022 to 2023.
- There was a significant increase in sales from 2020 to 2021, followed by a slight decrease in 2022.
- Overall, there has been a general upward trend in sales over the four-year period, with some fluctuations in between.

These revenue figures provide insights into the company's performance and can be used to analyze its growth and market position over the years.

Balance Sheet

These are balance sheets. Here are the conclusions:

1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with a significant portion in cash equivalents and short-term investments.
3. Non-current assets consist mainly of investments and advances, along with machinery, furniture, and equipment.
4. Total liabilities have also been increasing, but at a slower pace compared to assets.
5. Shareholders' equity has shown a positive trend, indicating a healthy financial position.
6. The company has been investing in non-current assets, which could indicate growth and expansion strategies.
7. There is a consistent level of short-term debt and accounts payable over the years.
8. The company has been retaining earnings and maintaining a stable level of common stock.
9. Overall, the financial health of the company seems to be strong and stable, with a focus on growth and maintaining a good equity position.

Cash Flow 💶

This is the cash flow statement. Here are some conclusions we can draw from the data:

1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. Financing activities show a pattern of common stock repurchase and issuance, as well as long-term debt issuance and payments.
5. Investing activities include the sale and purchase of investments, capital expenditures, and other investing activities.
6. The end cash position has also been fluctuating, reaching its highest value in 2020.
7. Stock-based compensation has been a significant factor in the company's financial activities.
8. The company has been paying dividends to common shareholders, with varying amounts each year.
9. The company's net income has been relatively stable over the years.
10. The company has been managing its cash flow effectively to maintain a healthy cash position.

Earnings estimate

Based on the analysts' estimates for future quarterly and annual earnings per share:

1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.

2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.

3. Looking at the estimates for the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous fiscal year.

4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a slight improvement from the EPS of $6.10 in the current fiscal year.

Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for the company in both the short term and the long term.

Revenue estimate

The analysts' estimates for the future quarterly and annual sales of the company indicate a moderate growth trend.

For the current quarter ending on June 30, 2024, the average estimate is $77,545,400,000, representing a 2% increase from the same quarter last year. The number of analysts providing estimates is 25.

Looking at the next quarter ending on September 30, 2024, the average estimate is $85,501,800,000, with a sales growth of 3% compared to the previous year. The number of analysts remains at 25.

For the current fiscal year ending on September 30, 2024, the average estimate is $357,772,000,000, showing a 1% growth from the previous year. The number of analysts providing estimates for the annual sales is 38.

In the following fiscal year ending on September 30, 2025, the average estimate is $380,772,000,000, indicating a more significant growth of 6% from the current fiscal year. The number of analysts remains at 38.

Overall, the estimates suggest a steady growth trajectory for the company's sales in both the short term and the long term.

Growth estimates

Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:

1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.

These estimates suggest that the company is expected to experience a moderate growth rate in the near term compared to the high growth rate observed in the past 5 years. However, the growth rate is projected to pick up slightly in the next year and remain steady over the next 5 years.

Price target

Based on the analysts' forecast, the future price of the security is expected to range between $164 (low) and $250 (high), with a median estimate of $200 and an average estimate of $202.26. The current price of the security is $191.57.

MACD of DMCC

This is not investment advice. Remember to verify the information provided here.

Get access to the full analysis

  • Over 35 000 indexes
  • CFD, Forex, Crypto and Stocks Exchange
  • Over 150 Indicators
  • Pattern and candle analysis
  • Support and resistance levels
  • Fundamental, technical and sentimental analysis
  • Power from AI
Web versionApp StoreGoogle Play

Contacts

Telephone number

+48 32 700 81 66

Email address

[email protected]

Company information

Honey Payment Group S.A. at Al. Aleje Jerozolimskie 65 / 79, 00-697 Warsaw, Poland, Register number KRS 0000335507, NIP 5252859204, REGON 388760204. Honey Payment Group is listed on the Warsaw Stock Exchange (WSE) under the ticker symbol HPG. Link